Jiangsu Hengrui Medicine
600276.SS
#526
Rank
C$68.51 B
Marketcap
C$10.32
Share price
1.94%
Change (1 day)
3.78%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): C$0.20

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.21. In 2025 the company made an earnings per share (EPS) of C$0.24 an increase over its 2024 EPS that were of C$0.19.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.20-15.01%
2025C$0.2424.14%
2024C$0.1942.43%
2023C$0.148.77%
2022C$0.13-20.62%
2021C$0.16-26.59%
2020C$0.2227.24%
2019C$0.1728.41%
2018C$0.1320.04%
2017C$0.1131.21%
2016C$0.0835611.46%
2015C$0.0749636.27%
2014C$0.0550119.77%
2013C$0.0459318.05%
2012C$0.0389123.9%
2011C$0.0314026.9%
2010C$0.0247512.37%
2009C$0.0220256.6%
2008C$0.014069.18%
2007C$0.01288114.48%
2006C$0.00600664.83%
2005C$0.00364435.55%
2004C$0.00268829.73%
2003C$0.00207219.86%
2002C$0.001729-2.71%
2001C$0.0017771.02%
2000C$0.001759